Log in | Register

Log in

Forgot your password?
Not a member?

Home > News

News

A new Measles-Rubella vaccine prequalified by WHO: Another affordable option for vaccine supply
Geneva, 29 September 2019 - A new measles-rubella (MR) vaccine has been prequalified by the World Health Organization (WHO) Biological E (BioE), a leading vaccine manufacturer in India, thanks to a partnership with PATH. Like measles, rubella is known for the...
View details
LG Chem received a $33.4 million grant from the Bill & Melinda Gates Foundation to develop a 6-in-1 combination vaccine to prevent childhood diseases
11 March 2019 - LG Chem announced that it will receive support from the Bill & Melinda Gates Foundation for the development of a hexavalent vaccine to prevent six diseases ― diphtheria, tetanus, whooping cough (pertussis), hepatitis B, haemophilus influenzae...
View details

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | 17

Partners:

DCVMN

DCVMN is a voluntary public health driven alliance of vaccine manufacturers from developing countries that aims to make a consistent supply of high quality vaccines that are accessible to protect people against known and emerging infectious diseases globally.

About us Contact us

Become a member footer

Become a member Register

© 2019DCVMN